AHA

THE AHA IDENTIFIES WHATLEY KALLAS AS A LAW FIRM WITH EXPERIENCE TO REPRESENT HOSPITALS PURSUING CLAIMS FOR 340B DRUG PAYMENTS AGAINST MEDICARE ADVANTAGE PLANS

The American Hospital Association has issued a Special Bulleting alerting its members contracted with Medicare Advantage plans that they may have claims for reimbursement for underpayments under the 340B Drug Pricing Program. The Special Bulletin advised members: To assist members in this effort, we have identified and spoken with four outside law firm that have […]

THE AHA IDENTIFIES WHATLEY KALLAS AS A LAW FIRM WITH EXPERIENCE TO REPRESENT HOSPITALS PURSUING CLAIMS FOR 340B DRUG PAYMENTS AGAINST MEDICARE ADVANTAGE PLANS Read More »

AHA URGES CONGRESS TO INCREASE ITS OVERSIGHT OVER MEDICARE ADVANTAGE PLANS

In a strongly worded letter in advance of a Congressional hearing on Medicare Advantage plans, the American Hospital Association urged Congress to increase its oversight over these plans, stating: “strong, decisive, and immediate enforcement action is needed to protect sick and elderly patients, the providers who care for them, and American taxpayers….” In support of

AHA URGES CONGRESS TO INCREASE ITS OVERSIGHT OVER MEDICARE ADVANTAGE PLANS Read More »

SUPREME COURT OVERTURNS MEDICARE RULE THAT SIGNIFICANTLY REDUCED PAYMENTS TO 340B HOSPITALS FOR OUTPATIENT DRUGS

On June 15, 2022, the Supreme Court issued a unanimous ruling in American Hospital Association et al. v. Becerra, overturning Medicare rules that significantly reduced payments to 340B hospitals for outpatient drugs. The specific issue in the case was whether the Department of Health and Human Services had the authority under the Medicare Prescription Drug,

SUPREME COURT OVERTURNS MEDICARE RULE THAT SIGNIFICANTLY REDUCED PAYMENTS TO 340B HOSPITALS FOR OUTPATIENT DRUGS Read More »

Scroll to Top